Abstract
Background
The ability to predict cardiometabolic multimorbidity (CMM) could significantly facilitate the identification of and intervention for middle-aged and older Chinese adults at risk. This study aimed to develop a prediction model for CMM progression trajectories based on multidimensional risk factors using an ensemble machine learning approach.
Methods
Data from 4,518 participants were obtained from the World Health Organization’s Study on Global AGEing and Adult Health (SAGE) in China, covering the period from 2007 to 2019. Information on the incidence of cardiometabolic diseases (CMDs) was collected via self-reported surveys. CMM was defined as the presence of at least two CMDs, including hypertension, diabetes, angina, stroke, and obesity. A multi-state model was used to examine the influence of multidimensional factors on the transition from health to a single CMD and subsequently to CMM. Predictive models for these transitions were then developed.
Results
During follow-up, 52.19% of initially healthy individuals developed one cardiometabolic disease (CMD), among whom 15.61% progressed to CMM. Female, low GDP per capita, unhealthy behaviors, elevated PM2.5 concentrations, low humidity, and low temperatures were identified as shared risk factors across the progression from health to CMD and from CMD to CMM. Moreover, in the health-to-CMD transition, older age, low educational level, and physical fitness impairment emerged as independent risk factors. Distinctively, in the CMD-to-CMM transition, IC impairment was identified as an independent influencing factor. Using these key predictors, a stacking ensemble model incorporating five machine learning algorithms was developed, and the model demonstrated area under the curve (AUC) values of 0.89 (95% CI: 0.88–0.91) for predicting the transition from health to CMD, and 0.76 (95% CI: 0.72–0.82) for predicting progression from CMD to CMM.
Conclusion
In conclusion, this study demonstrates that a stacking ensemble model based on multidimensional factors can effectively predict the progression of CMM. Our study not only identified distinct risk factors for different transitional stages but also highlighted the potential of machine learning to improve early risk stratification and inform targeted interventions for preventing CMM in the aging.
Keywords: cardiometabolic multimorbidity, risk factors, prediction model, cohort study, middle-aged and older Chinese adults
Introduction
Multimorbidity is a critical global health challenge since it reduces life quality and greater use of health-care resources (1). In China, rapid population aging has resulted in a significant burden of multimorbidity (2), and a study reported that 68.50% individuals aged 75 years and older suffered from multimorbidity (3). Cardiometabolic multimorbidity (CMM), defined as the simultaneous presence of at least two cardiometabolic diseases (CMDs), is one of the most frequently observed and replicable multimorbidity profiles (4, 5). The prevalence of CMM in Chinese adults (≥ 45 years) is 24.5% (6), which is higher than other frequently identified multimorbidity pattern, such as degenerative multimorbidity, which stands at 14.58% (7). Compared with participants without multimorbidity, those with CMM demonstrated twofold increased risk of mortality (8), while experiencing a life expectancy reduction of up to 15 years (9).
Identifying the key factors of CMM facilitates targeted prevention and control strategies. A prior prospective cohort study has identified unhealthy lifestyles, such as smoking, higher alcohol consumption and lower physical activity were associated with multimorbidity incidence in Europe elderly (10). A large prospective cohort study from the UK revealed that air pollutants play a hazardous role in the progression trajectory of CMM (11). However, previous studies often concentrate on merely one or two dimensions of risk factors, lacking a comprehensive, multidimensional framework for CMM. This fragmented focus inevitably obscures the stage-specific nature of various determinants across different phases of CMM progression. Since the factors associated with the onset of a first CMD may differ from those related to progression toward CMM, identifying stage-specific determinants may help inform targeted prevention strategies. However, evidence on such heterogeneity across different stages of CMM progression remains limited. Furthermore, those studies assumed that the risk factors remained unchanged throughout the entire follow-up period, which may lead to bias (12, 13).
Prediction model based on machine learning (ML) serves a crucial role in the early detection and intervention of CMM (14). For instance, a U. S. study has confirmed that a warning system based on gradient boosted trees reduced mortality risk by 18% in hospitalized sepsis patients (15), while a doctor-led mobile health intervention based on the China-PAR model achieved a 6.3% reduction in 10-year risk of atherosclerotic cardiovascular diseases among rural residents ((16, 17)). In China, although notable advancements have been achieved in developing predictive models for a single CMD (18, 19), a significant gap remains in the development of prediction models on CMM trajectory. Furthermore, prior studies have mostly relied on single prediction model, which may exhibit instability in performance. In contrast, ensemble learning, which uses a meta-learner to integrate predictions from multiple models, frequently achieving superior performance compared to individual model (20, 21).
This study used data from the World Health Organization Study on Global Ageing and Adult Health (WHO SAGE) China to develop prediction model on the trajectory of CMM based on multidimensional risk factors. Our findings are helpful to improve early risk stratification and inform targeted interventions for preventing CMM in rapid aging China.
Methods
Study design and participants
All participants were selected from WHO SAGE, a prospective cohort study in six countries (China, Ghana, India, Mexico, Russia, and South Africa) (22). The Chinese part of the SAGE was conducted in seven provinces (Jilin, Zhejiang, Shandong, Guangdong, Hubei, Shaanxi, and Yunnan) and one municipality (Shanghai), with one rural and one urban site selected in each region. People aged 50 years and over were selected as the study participants using a stratified multistage random cluster sampling (23).
This study utilized a dynamic cohort design based on three waves of the SAGE China study: Wave 1 (2007–2010), Wave 2 (2014–2015), and Wave 3 (2018–2019). To make full use of the longitudinal data, we included participants who completed at least two surveys. The analytic sample comprised participants enrolled in Wave 1 who were followed up in Wave 2 and/or Wave 3, as well as those who were newly recruited in Wave 2 and subsequently followed up in Wave 3. Integrating these groups maximizes the total sample size available for estimating transition probabilities across the progression of CMM. From an initial pool of 18,673 participants across all waves, we applied the following exclusion criteria: (1) failed to complete at least one subsequent follow-up; (2) aged <50 years at their respective baseline; (3) had missing data on key variables; (4) had prevalent CMDs at baseline. Ultimately, a total of 4,518 participants were included in the final analysis (Supplementary Figure S1).
Identification of chronic diseases
In this study, CMM was defined as the coexistence of at least two of the following five conditions: obesity, hypertension, diabetes, angina, stroke. The selection of these five specific diseases is empirically supported by prior clustering evidence utilizing the WHO SAGE database and is consistent with previous epidemiological studies of CMM (5, 24). Obesity is specifically identified when an individual’s body mass index (BMI) is equal to or greater than 30, while the status of other chronic disease was assessed by two questions. For instance, “Have you ever been diagnosed with hypertension during last 12 months?” and “Have you been taking any medications or other treatments for this hypertension last 12 months?” If either of the two questions in the questionnaire has an answer of “Yes,” then we will define the respondent as a hypertension case (25).
Data collection
Baseline data were collected through face-to-face interviews with all enrolled participants. During follow-up investigations, participants also underwent similar face-to-face interviews to update information on morbidity. The study was approved by the Ethics Committee of the Chinese Centre for Disease Control and Prevention (approval number: 200601), and by the Shanghai Municipal Center for Disease Control and Prevention (approval number: 2014-8, 2018-1). Informed consent was obtained from each participant before the investigation.
Risk factors
According to prior studies (11, 16, 17, 26, 27), this study on multimorbidity based on five dimensions: socio-demographic characteristics, behavioral factors, physiological indicators, IC and environmental exposure. Socio-demographic dimensions incorporate sex, age, marital status, education, Gross Domestic Product (GDP) per capita. Behavioral factors integrate smoking status, drinking status, physical activity, social engagement, and vegetable intake. Physiological indicators include grip strength, pulmonary function, pulse and blood pressure. Intrinsic capacity (IC) focuses locomotion, vitality, cognition, depression, sensory. We constructed unhealthy behavior scores, physical fitness impairment scores and IC impairment scores with different modifiable factors, respectively. Participants were assigned 1 point for each factor against with guidelines and recommendations, with higher scores indicating worse adherence to the corresponding domain. For instance, behavior factors domain included five conventional factors (smoking status, drinking status, physical activity, social engagement and vegetable intake), and the participants who reported smoke, drink, low physical activity, insufficient social engagement and inadequate vegetable intake accumulated up to 5 points in “unhealthy behavior” variable. Details of the definitions of risk factors were showed in Supplementary Table S1, and Supplementary Tables S2–S4 outline the specific scoring criteria for unhealthy behavior, physical fitness impairment and IC impairment.
For environmental exposure, we include ambient fine particulate matter less than 2.5 (PM2.5), average temperature and relative humidity. PM2.5 data were obtained from the high-resolution (1 km × 1 km) daily dataset provided by the National Earth System Science Data Center’s Shared Service Platform1. Validation studies of this dataset demonstrate excellent agreement with ground monitoring stations, showing a coefficient of determination (R2) of 0.92 and root mean square error (RMSE) of 10.76 μg/m3. The meteorological data include the annual average temperature and relative humidity are derived from the Fifth Generation Atmospheric Reanalysis Dataset (ECMWF ReAnalysis 5, ERA5) of the European Centre for Medium-Range Weather Forecasts. The ERA5 dataset provides a latitude-longitude network with a spatial resolution of 0.1° × 0.1° (equivalent to approximately 9 km × 9 km in the mid-latitude region). For each participant, we extracted daily environmental data based on geographic coordinates and estimated average exposures of PM2.5 concentrations, temperature and relative humidity values from the 1 year preceding each investigation to the survey date.
Demographic characteristics were assessed at baseline, whereas other variables were updated at each wave. This time-updated approach captures the dynamic status of participants during each transition interval across the entire follow-up period.
Missing values in variables were imputed using multiple imputation by chained equations (MICE), ensuring the robustness of the analyses.
Statistical analysis
Multi-state model
In the study, two transition stages of multimorbidity were established: (1) Health to CMD; (2) CMD to CMM. For each participant, survival time was calculated from baseline until either the occurrence of the respective transition event or censoring, whichever occurred first. The exact date of a transition event was determined by the survey date where the diagnostic criteria were first met. Participants who remained event-free at the final follow-up or were lost to follow-up were defined as censoring. We further adopted the unidirectional multi-state model with Markov proportional hazards, an extension of the conventional Cox model, to simultaneously investigate the impact of multidimensional factors on different phases of disease progression (i.e., Health, to CMD, to CMM). The formula was presented as follow:
In this multi-state model, represents the instantaneous transition hazard from state i to state j at time t, given a set of covariates Z, while denotes the baseline hazard for the same transition when all covariates are set to zero. Here, Z represents the covariate vector, and corresponds to the regression coefficients specific to the transition of i to j. A Markov proportional hazards model was incorporated to evaluate the effects of these covariates on different transition pathways simultaneously.
Machine learning algorithms
Candidate predictors were primarily selected based on previous epidemiological evidence (11, 16, 17, 26). To further refine the feature set, we incorporated all potential risk factors (p < 0.05) identified in the progression trajectory of CMM into the prediction models. The dataset was partitioned into training (70%) and testing (30%) subsets using random sampling to preserve outcome distribution across both sets. This approach ensured the training set would be used for model development while maintaining an independent testing set for unbiased performance evaluation.
The stacking ensemble model is a ML technique that combines multiple base models to improve predictive performance. The stacking framework operates through a hierarchical structure comprising two key components: base models and a meta-model. In stacking, meta-models are trained to learn how to best combine the predictions of the base models. During the first stage, each base-model classifier is independently trained on the initial training dataset. These base models then generate predictions that serve as input features for the subsequent meta-learner. First, we used five algorithms, eXtreme Gradient Boosting (XGBoost), Random Forest (RF), Logistic Regression (LR), Support Vector Machine (SVM), and Neural Network (NN) as the base models, which were widely used in the study of diseases prediction (27, 28). To ensure robust generalization and prevent overfitting, we utilized a 5-fold cross-validation (CV) strategy on the training dataset to generate “out-of-fold” predictions. Specifically, the training set was divided into five subsets; each base model was trained on four subsets and made predictions on the remaining “held-out” subset. This process was rotated until every observation in the training set had a corresponding meta-feature generated by each base model. Hyperparameters for all base models were optimized via grid search within the internal CV loops. Second, logistic regression was chosen as a meta-model, which effectively aggregated the predictions from base models to improve overall predictive accuracy (29). In this study, the aim of using an integrated ML model is to take full advantage of different classes of the five different ML algorithms and improve the overall performance of the prediction model. Finally, the performance of the fully trained stacking ensemble was evaluated on a completely independent test set (30% of the total sample) using AUC-ROC, sensitivity, specificity, accuracy, Brier score, calibration slope and intercept.
To visually interpret the global predictive contribution of multi-dimensional features to the ultimate decisions of the integrated framework, a weighted ensemble SHapley Additive exPlanations (SHAP) approach was further developed. The empirical regression coefficients of each base learner were extracted from the trained meta-learner and normalized to serve as weights. Subsequently, individual SHAP matrices for the five base learners (XGBoost, Random Forest, Logistic Regression, Support Vector Machine, and Neural Network) were first computed on the independent 30% testing dataset via the fastshap algorithm. The overall stacking SHAP values were then derived via a weighted linear combination of the individual base learners’ SHAP matrices ( ). The final global feature importance was ranked and visualized using the mean absolute SHAP values for the health-to-CMD and CMD-to-CMM transitional stages, respectively.
Furthermore, multicollinearity among all candidate predictors from multiple domains was rigorously assessed using the Variance Inflation Factor (VIF). All candidate variables exhibited VIF values well below the conservative threshold of 5 (with all VIFs < 1.6), demonstrating the absence of severe multicollinearity in our multi-dimensional framework (Supplementary Figure S2).
Sensitivity analysis
To assess the robustness of our primary findings, we conducted several sensitivity analyses: (i) adjusting the exposure duration (2 and 3 years) of the ambient PM2.5 concentrations, temperature and relative humidity; (ii) employing traditional Cox proportional hazards models to analyze each distinct state transition individually. (iii) Excluding respondents with other pre-existing chronic conditions at baseline and re-establishing the prediction models to observe the changes in there predictive performance. (iv) Re-fitting the multi-state model using a random 70% subsample to ensure that the feature selection remained stable. (v) Redefining obesity using the population-specific cut-off for Chinese temporal traits (BMI ≥ 28 kg/m2) and re-fitting both the multi-state trajectory models and the machine learning predictive frameworks to evaluate the robustness.
Data analysis was performed with the statistical software package R (v4.4.1). The R packages survival, msm, mstate were utilized for statistical analysis, and a p-value < 0.05 was considered statistically significant.
Results
Descriptive results
The baseline characteristics of the 4,518 study participants are summarized in Table 1. The demographic breakdown revealed that 52.43% (n = 2,369) were male, 45.79% (n = 2,069) were aged ≥ 60 years, 87.78% (n = 3,966) were married, and 68.39% (n = 3,090) had at least a primary education. Half of the cohort (53.61%, n = 2,422) lived in low-GDP counties. Mean values for IC impairment, unhealthy behavior and physical fitness impairment scores were 1.72 (±1.34), 2.01 (±1.03), and 1.33 (±0.75), respectively. The average annual environmental exposures were 54.32 ± 13.03 μg/m3 for PM2.5, 15.40 ± 4.05 °C for temperature, and 71.41 ± 5.23% for relative humidity. Compared to the baseline healthy status, those progressing to CMD and CMM had higher aging and unmarried proportion, as well as increased level of IC impairment, unhealthy behavior and physical fitness impairment.
Table 1.
Basic information of the study participants during CMM progression.
| Group | Number (%) / Mean ± sd | ||
|---|---|---|---|
| Health (Baseline) | CMD | CMM | |
| Total | 4,518 (100.00%) | 2,358 (52.19%) | 368 (15.61%) |
| Sex | |||
| Male | 2,369 (52.43%) | 1,254 (53.18%) | 183 (49.73%) |
| Female | 2,149 (47.57%) | 1,104 (46.82%) | 185 (50.27%) |
| Age (year) | |||
| <60 | 2,449 (54.21%) | 411 (17.43%) | 48 (13.04%) |
| ≥60 | 2,069 (45.79%) | 1,947 (82.57%) | 320 (86.96%) |
| Marital status | |||
| Married | 3,966 (87.78%) | 2,031 (86.13%) | 313 (85.05%) |
| Unmarried | 552 (12.22%) | 327 (13.87%) | 55 (14.95%) |
| Education | |||
| Less than primary | 1,428 (31.61%) | 822 (34.86%) | 114 (30.98%) |
| Primary and above | 3,090 (68.39%) | 1,536 (65.14%) | 254 (69.02%) |
| GDP per capita (Yuan) | |||
| High | 2,096 (46.39%) | 1,085 (46.01%) | 206 (55.98%) |
| Low | 2,422 (53.61%) | 1,273 (53.99%) | 162 (44.02%) |
| IC impairment | 1.72 ± 1.34 | 2.06 ± 1.45 | 2.47 ± 1.44 |
| Unhealthy behavior | 2.01 ± 1.03 | 2.72 ± 1.10 | 2.74 ± 1.14 |
| Physical fitness impairment | 1.33 ± 0.75 | 1.50 ± 0.71 | 1.59 ± 0.77 |
The IC impairment was calculated based on mobility, vitality, cognition, depression and sensory (range 0–5). Unhealthy behavioral was calculated based on smoking, drinking, physical activity, social status and vegetable intake (range 0–5). Physical fitness impairment was calculated based on grip strength, lung capacity, pulse rate and prehypertension (range 0–4). Details are provided in Supplementary Tables S2–S4.
The progression trajectories of CMM
During a median follow-up of 8.72 years, 52.19% (2,385) of initially healthy people developed a single CMD, of whom 15.61% (368) progressed to CMM. From health to CMD, 2,098 (46.44%) of CMDs were hypertension, 42 (0.93%) were diabetes, 98 (2.17%) were angina, 88 (1.95%) were stroke, and 32 (0.71%) were obesity. Compared with participants with diabetes, angina, stroke and obesity, participants with hypertension, were more likely to develop CMM. Stage-specific transitions are detailed in Figure 1.
Figure 1.
Status transition of CMD. (A) The numbers (percentages) of participants from health to all CMD and CMM. (B) The numbers (percentages) of participants from health to specific CMD and from specific CMD to CMM.
Risk factors of CMM progression trajectories
Multi-state analyses showed that female (HR = 1.12, 95% CI: 1.04–1.20), older age (HR = 1.15, 95% CI: 1.08–1.22), unhealthy behavior (HR = 1.07, 95% CI: 1.02–1.12), physical fitness impairment (HR = 1.15, 95% CI: 1.09–1.21) and elevated PM2.5 concentrations (HR = 1.04, 95% CI: 1.03–1.05) significantly increased the risk from health to develop CMD, while higher education levels (HR = 0.91, 95% CI: 0.86–0.97), higher GDP per capita (HR = 0.75, 95% CI: 0.71–0.80), and warmer ambient temperature (HR = 0.96, 95% CI: 0.95–0.97) demonstrated significant protective effects (Figure 2A). Female (HR = 1.22, 95% CI: 1.03–1.45), IC impairment (HR = 1.16, 95% CI: 1.07–1.25), elevated PM2.5 concentrations (HR = 1.08, 95% CI: 1.07–1.09) were significantly associated with an increased risk from CMD to CMM, while higher relative humidity (HR = 0.97, 95% CI: 0.96–0.98) and warmer temperature (HR = 0.93, 95%CI: 0.90–0.96) was protective factors (Figure 2B).
Figure 2.
The muti-state model analysis of multidimensional risk factors. (A) Hazard ratios (HRs) and 95% confidence intervals (CIs) from health to CMD. (B) Hazard ratios (HRs) and 95% confidence intervals (CIs) from CMD to CMM. CMD: cardiometabolic disease (hypertension, diabetes, angina, stroke or obesity); CMM, cardiometabolic multimorbidity: a status with at least two CMDs. ***: Significant interaction effect at p < 0.001, **: Significant interaction effect at p < 0.01, *: Significant interaction effect at p < 0.05, †: Marginal effect at p < 0.1. Ref: Sex (male), Age (<60 years), Education (less than primary), GDP per capita (Low), PM2.5 (per 1 μg/m3).
Prediction models for CMM multimorbidity trajectories
Based on the key risk factors abovementioned, we first developed prediction models of CMM trajectories using five algorithms: XGBoost, RF, LR, SVM, and NN. All models exhibited predictive capability across transitions from healthy status to CMD, with better performance for XGBoost (AUC = 0.89, 95%CI: 0.88–0.91) and RF (AUC = 0.89, 95%CI: 0.87–0.90), followed by NN (AUC = 0.88, 95% CI: 0.86–0.90), SVM (AUC = 0.84, 95% CI: 0.82–0.85) and LR (AUC = 0.80, 95% CI: 0.78–0.82). For CMD to CMM, models showed moderate performance for XGBoost (AUC = 0.74, 95% CI: 0.68–0.79), RF (AUC = 0.74, 95% CI: 0.69–0.80), LR (AUC = 0.73, 95% CI: 0.68–0.78) and NN (AUC = 0.72, 95% CI: 0.66–0.77) (Figure 3).
Figure 3.
ROC curve and calibration curve of the Machine Learning prediction models. (A) ROC curve: Health to CMD; (B) ROC curve: CMD to CMM; (C) Calibration curve: Health to CMD; (D) Calibration curve: CMD to CMM.
We further developed a stacking ensemble model by integrating the five algorithms. The models demonstrated robust diagnostic performance for trajectory from health to CMD and from CMD to CMM, achieving an AUC of 0.89 (95%CI: 0.88–0.91) and 0.76 (95%CI: 0.72–0.82), respectively. Moreover, the ensemble learning models demonstrated well overall predictive performance. The prediction model for transitions from health to CMD showed high sensitivity (0.74), specificity (0.98), and accuracy (0.85), while the model for CMD to CMM progression attained corresponding values of 0.65, 0.78 and 0.76, respectively. Additionally, calibration performance was satisfactory for both transitions. For the Health-to-CMD transition, the Stacking model achieved a Brier score of 0.12, a calibration slope of 0.93, and an intercept of 0.02. For the CMD-to-CMM transition, the corresponding values were 0.12, 1.05, and −0.02, respectively. The other detailed information on the stacking ensemble model is presented in Supplementary Figures S3, S4 and Supplementary Tables S5, S6.
To further interpret the predictive driving mechanism of the Stacking framework, global feature importance was evaluated using the mean SHAP values. For the transition from health to CMD, environmental factors along with GDP per capita and age emerged as the top 5 predictive risk factors (Figure 4A). In contrast, for the subsequent progression from CMD to CMM, while environmental exposures remained prominent, IC impairment and unhealthy behavior escalated into the top 5 key drivers (Figure 4B).
Figure 4.
Global feature importance of the predictive models based on the weighted Stacking ensemble SHAP approach. (A) Global feature importance ranked by the mean absolute overall SHAP values from health to CMD. (B) Global feature importance ranked by the mean absolute overall SHAP values from CMD to CMM.
Sensitivity analyses
The robustness of our findings was confirmed through a series of sensitivity analyses. First, to assess the robustness of our exposure definitions, we extended the period for calculating moving averages of ambient PM2.5, temperature, and relative humidity from 1–2 years and 3 years. The associations observed in the multi-state model remained virtually unchanged (Supplementary Tables S7, S8). Second, to verify the consistency of the risk factors identified by the multi-state model, we performed a traditional Cox regression analysis for each transition (Health to CMD, CMD to CMM) separately. The results were consistent with those from multi-state model, confirming the reliability of our core findings (Supplementary Table S9). Third, to ensure that our results were not confounded by other diseases, we repeated both the multi-state modeling and the machine learning prediction analyses in a sub-cohort excluding individuals. In this analysis, we excluded individuals who had pre-existing chronic conditions at baseline, including any of the five pre-defined CMDs or other chronic diseases (Supplementary Table S10). The identified risk factors (Supplementary Table S11) and the performance of the prediction models (Supplementary Tables S12, S13) in this healthy sub-cohort were also performed well. Additionally, to address concerns regarding potential data leakage in the prediction models, we re-fitted the multi-state model using a random 70% subsample. The significant predictors in this subsample were highly consistent with those identified in the full population, confirming that our feature selection was robust and independent of the test set (Supplementary Table S14). Finally, to address potential diagnostic variations in body composition metrics, we reperformed the complete workflow using the Chinese population-specific obesity threshold (BMI ≥ 28 kg/m2). Under this native criteria framework, both the hazard ratios in the multi-state trajectories and the predictive evaluation indicators of the Stacking framework demonstrated exceptional stability and closely matched the primary analysis results (Supplementary Tables S15–S17).
Discussion
In this national prospective cohort study in China, this study identified both common and distinct risk factors associated with the progression from health to CMD, from CMD to CMM. Notably, female, low GDP per capita, unhealthy behaviors, elevated PM2.5 concentrations, low humidity, and low temperatures were identified as shared risk factors across the progression from health to CMD and from CMD to CMM. Moreover, in the health-to-CMD transition, older age, low educational level, and physical fitness impairment emerged as independent risk factors. Distinctively, in the CMD-to-CMM transition, IC impairment was identified as an independent risk factor. The results highlight the complexity of disease progression pathways, emphasizing the need for stage-specific interventions. Based on the list of risk factors, we constructed two stacking ensemble models with good prediction performance by integrating five machine learning algorithms models, which achieved good prediction performance from health to CMD, further to CMM. Our finding could provide precise and feasible tools for early risk prediction and early warning of CMM.
Our study identified several shared risk factors that were consistently associated with disease progression, from health to CMD and onward to CMM. These include socio-demographic characteristics, lifestyle patterns and environmental exposures, creating a sustained pathogenic milieu across CMM stages. First, socio-demographic factors such as female and lower GDP per capita exert a dual-phase influence. The elevated risk of female might be attributable to post-menopausal hormonal shifts and vascular stiffness, which exacerbates cardiovascular risks (30). Moreover, lower GDP per capita may lead to fragmented healthcare systems and limited health-promoting resources, thereby possibly impeding effective chronic disease prevention and management (31). Second, modifiable behavioral factors, including smoking, excessive alcohol consumption, physical inactivity, poor diet, and limited social engagement, that were collectively related to progression from health to CMD and further to CMM, consistent with Western longitudinal studies (32–34). Specifically, tobacco use and chronic alcohol use promote systemic inflammation and endothelial dysfunction, while physical inactivity disrupts lipid metabolism (35, 36). Furthermore, inadequate vegetable intake deprives essential antioxidants, dietary fiber, and anti-inflammatory phytochemicals, thus affecting metabolic regulation and vascular health (37). Beyond these traditional risks, social isolation may induce chronic psychological distress, amplifying sympathetic activity, inflammation, and depressive symptoms, thereby accelerating disease progression (38, 39). Our study identified associations of both conventional and emerging lifestyle factors with CMM progression, suggesting emerging factors may aid in prevention, control and delay.
Beyond individual-level factors, our results underscored that environmental exposures are associated with the dynamics of multimorbidity. The consistent risk posed by PM2.5 across disease transitions, alongside the protective roles of warmer temperature and higher humidity. Fine particulate matter may acts as a pervasive biological stressor, promoting disease via pathways like autonomic imbalance and chronic inflammation (40–42). Conversely, cold and dry conditions appear to impose acute hemodynamic and rheological strain, precipitating events in vulnerable individuals (43, 44). Given that epidemiology has demonstrated that air purification and central heating have benefit on cardiovascular health (45, 46), our findings further encourage these adaption strategies against CMM.
Our study identified distinct risk factors at either the onset of the first chronic condition or its progression to multimorbidity. Older age, lower educational level and physical fitness impairment were associated with increased risk from health to CMD. As individuals age, they experience a gradual decline in physiological reserves across multiple organ systems, coupled with immunosenescence and progressive vascular aging, and probably promote the onset of vascular-related diseases (47, 48). Lower educational level may be associated with insufficient ability of individuals to obtain and understand health information, thereby affecting their health behaviors. In addition, our findings aligned with existing evidence indicating that physical fitness impairment is significant risk factors for CMDs (26, 49–51). For instance, grip strength reflects muscle health, and its decline is linked to elevated systemic inflammation and worsened insulin resistance (52). Similarly, impaired lung function necessitates increased cardiac output for oxygenation, imposing hemodynamic strain on the heart and vasculature (53). Excessive pulse and blood pressure variability induce hemodynamic stress that can damage end-organs such as the brain and heart, further raising CMD risk (54, 55).
Notably, we identified impaired IC as a significant predictor of progression from CMD to CMM, underscoring its considerable role in the transition toward greater multimorbidity. This is consistent with recent studies linking IC deficits to higher cardiometabolic incidence (56, 57) and functional decline over time (58, 59). IC encompasses five core domains, including locomotion, cognition, vitality, psychological state, and sensory function, which collectively reflecting the integration of multiple physiological systems. Its impairment may act through shared pathways such as chronic inflammation, neuroendocrine imbalance, and autonomic dysfunction (60, 61), not only as a marker but potentially tracking with multisystem dysregulation in individuals already burdened by an initial chronic condition, which suggesting that interventions aimed at preserving or restoring IC may interrupt the cascade toward additional multimorbidity.
This stage-specific divergence indicates that older age, lower education, and physical fitness impairment contribute more to the onset of the first chronic condition than to the later build-up of comorbidity, whereas IC impairment appears more relevant during the disease accumulation phase. Older age and lower educational attainment can be regarded as upstream determinants of disease onset (62–64). Aging is associated with the gradual accumulation of cardiometabolic risk, while individuals with higher education are generally more likely to access health information, adopt preventive behaviors, and seek timely medical care. Once a cardiometabolic disease is diagnosed, patients commonly receive regular medical follow-ups and health advice. This ongoing care helps close the gap in disease awareness that often exists between age and educational groups, and it shifts the main drivers of further disease accumulation toward disease management and treatment adherence, rather than leaving them dependent on chronological age or educational attainment alone. Similarly, physical fitness impairment may reflect early physiological vulnerability. Following the onset of a chronic disease, progression toward multimorbidity may be influenced more strongly by broader functional decline, thereby reducing the relative contribution of these early physiological indicators(65). In contrast, impaired IC may reflect reduced physiological reserve and resilience across multiple functional domains(66, 67). Among individuals who already have a cardiometabolic disease, lower IC may indicate a diminished capacity to cope with disease-related stressors, making them more susceptible to the development of additional chronic conditions.
To our knowledge, this study is the first to apply prediction models to integrate multidimensional factors to construct prediction models spanning the progression from health to CMD, subsequently to CMM, respectively. In China, a ten metabolites-based algorithm demonstrated robust predictive performance for type 2 diabetes (T2D) onset (AUROC = 0.89, 95%CI: 0.86–0.93) (68), which was comparable to our health-to-CMD prediction model (AUC = 0.89, 95%CI: 0.88–0.91). While prior research in China has established highly effective prediction models for individual CMD, studies addressing CMM prediction remain scare. Notably, our CMD-to-CMM prediction model (AUC = 0.76, 95%CI: 0.72–0.82) exhibited performance equivalent to a Cox regression prediction model for CMM events based on UK Biobank (AUC = 0.72, 95%CI: 0.71–0.73) (69). Furthermore, we constructed a stacking ensemble model integrating XGBoost, LR, RF, SVM and NN for CMM trajectories. Consistent with previous study (21), the stacking model demonstrated superior predictive performance compared to other single models, which could improve accuracy by reducing outliers to highlight its potential as a reliable approach for disease prediction (70). Our prediction models could provide a certain support for the early identification and intervention of CMM.
This study underscores key public health implications for CMM progression. It identifies both shared risk factors (e.g., unhealthy behaviors, environmental exposures) acting across stages from CMD and to CMM, and stage-specific factors (e.g., physical fitness in initial onset, intrinsic capacity in progression to multimorbidity). This highlights the necessity for integrated interventions targeting common risks throughout the disease progression, complemented by stage-tailored strategies addressing distinct factors at each transition. Furthermore, the developed stacking ensemble prediction models enable early risk prediction and warning for both transitions. Implementing such models facilitates timely, precise interventions, which is crucial for delaying or preventing the progression to multimorbidity.
Strengths and limitations
Our study presents several strengths. First, we considered multidimensional factors rather than relying on a single dimension, enabling a comprehensive characterization of risk factors influencing the progression trajectory of CMM. Second, this is the first use of ensemble model to predict the progression of CMM in a Chinese population, contrasting with conventional single-model prediction frameworks. Several limitations should also be acknowledged. First, the cohort had a limited number of follow-up visits, which may limit the capacity to capture long-term CMM progression dynamics. Second, ambient environmental exposure in our study were estimated based on participants’ residential addresses without accounting for daily activities and location, potentially introducing exposure misclassification. Third, some environmental pollutants were not available prior to 2013 (e.g., SO2, NO2, CO). Consequently, only PM2.5 was taken into consideration. Additionally, certain conditions such as obesity may be reversible; however, the multi-state model assumed irreversible transitions, which may not fully capture instances of health recovery. Finally, the shorter follow-up for Wave 2 recruits might limit the observation of disease progression events within the study period.
Conclusion
In conclusion, this prospective cohort of middle-aged and older Chinese adults revealed that CMM progression is driven by both shared risk factors and stage-specific factors. We developed good-performance prediction models for both the health-to-CMD and CMD-to-CMM transitions. These findings support implementing integrated public health interventions targeting common risks, alongside stage-targeted strategies enabled by early prediction, to effectively delay or prevent CMM.
Acknowledgments
We are deeply grateful to all the members and participants of SAGE for their invaluable and outstanding contributions.
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Key Research and Development Program of China (2023YFC3605000), Guangdong Provincial Center for Disease Control and Prevention Talents Support Program (No. 0920260120), the National Natural Science Foundation of China (42505175; 42075173; and 42275187), the Medical and Young Elite Scientists Sponsorship Program by CAST (2022QNRC001), the Science and Technology Program of Liwan District, Guangzhou (20240601), and the Shenzhen Science and Technology Program (JCYJ20250604185826035).
Edited by: Elisabetta Tonet, University Hospital of Ferrara, Italy
Reviewed by: Dan Liu, Southern Medical University, China
Jiafeng Zhang, Shanghai Changzheng Hospital, China
Abbreviations: WHO-SAGE, World Health Organization Study on Global Ageing and Adult Health; CMM, Cardiometabolic multimorbidity; CMDs, Cardiometabolic diseases; AUC, Area under the curve; BMI, Body mass index; ML, Machine Learning; XGBoost, eXtreme Gradient Boosting; RF, Random Forest; LR, Logistic Regression; SVM, Support Vector Machine; NN, Neural Network; AUC-ROC, Area under the receiver operating characteristic curve; GDP, Gross Domestic Product; IC, Intrinsic capacity; HR, Hazard ratio; CI, Confidence interval; SBP, Systolic blood pressure; DBP, Diastolic blood pressure.
Data availability statement
The data analyzed in this study is subject to the following licenses/restrictions: the datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Requests to access these datasets should be directed to heguanh1991@163.com (GH).
Ethics statement
The studies involving humans were approved by Chinese Centre for Disease Control and Prevention (approval number: 200601) and Shanghai Municipal Center for Disease Control and Prevention (Approval Number: 2014-8, 2018-1). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
LX: Methodology, Writing – review & editing, Writing – original draft. FeW: Writing – original draft, Data curation. HL: Formal analysis, Writing – original draft. ZW: Formal analysis, Writing – review & editing. ZL: Writing – review & editing. KL: Writing – review & editing. JH: Methodology, Writing – review & editing. ZH: Formal analysis, Writing – review & editing. YY: Writing – review & editing, Formal analysis. JZ: Writing – review & editing, Formal analysis, Methodology. JW: Writing – review & editing, Formal analysis. ZZ: Formal analysis, Writing – review & editing. TL: Methodology, Writing – review & editing. WM: Funding acquisition, Writing – review & editing, Methodology, Supervision. FaW: Data curation, Writing – review & editing. GH: Methodology, Funding acquisition, Writing – review & editing, Writing – original draft.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The reviewer DL declared a past co-authorship with the authors JH, WM, and GH to the handling editor.
Generative AI statement
The author(s) declared that Generative AI was used in the creation of this manuscript. Refine the phrasing of the article.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2026.1890290/full#supplementary-material
References
- 1.van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. (2009) 2:65–70. doi: 10.3109/13814789609162146 [DOI] [Google Scholar]
- 2.Su P, Ding H, Zhang W, Duan G, Yang Y, Chen R, et al. The association of multimorbidity and disability in a community-based sample of elderly aged 80 or older in Shanghai, China. BMC Geriatr. (2016) 16:178. doi: 10.1186/s12877-016-0352-9, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhao Y, Atun R, Oldenburg B, McPake B, Tang S, Mercer SW, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. (2020) 8:e840–9. doi: 10.1016/S2214-109X(20)30127-3, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Busija L, Lim K, Szoeke C, Sanders KM, McCabe MP. Do replicable profiles of multimorbidity exist? Systematic review and synthesis. Eur J Epidemiol. (2019) 34:1025–53. doi: 10.1007/s10654-019-00568-5, [DOI] [PubMed] [Google Scholar]
- 5.Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. (2014) 67:254–66. doi: 10.1016/j.jclinepi.2013.09.021, [DOI] [PubMed] [Google Scholar]
- 6.Huang ZT, Luo Y, Han L, Wang K, Yao SS, Su HX, et al. Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese. J Affect Disord. (2022) 301:1–7. doi: 10.1016/j.jad.2022.01.030, [DOI] [PubMed] [Google Scholar]
- 7.Liu C., Chen M. S. (2024). Network and patterns of multimorbidity among middle-aged and elderly patients with chronic diseases in China. Chin Health Econ, 43, 57–60, 65. [Google Scholar]
- 8.Fan J, Sun Z, Yu C, Guo Y, Pei P, Yang L, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J. (2022) 135:648–57. doi: 10.1097/cm9.0000000000001985, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. (2015) 314:52–60. doi: 10.1001/jama.2015.7008, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. (2020) 18:5. doi: 10.1186/s12916-019-1474-7, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zou H, Zhang S, Cai M, Qian ZM, Zhang Z, Chen L, et al. Ambient air pollution associated with incidence and progression trajectory of cardiometabolic diseases: a multi-state analysis of a prospective cohort. Sci Total Environ. (2023) 862:160803. doi: 10.1016/j.scitotenv.2022.160803, [DOI] [PubMed] [Google Scholar]
- 12.Li R, Cai M, Qian ZM, Wang X, Zhang Z, Wang C, et al. Ambient air pollution, lifestyle, and genetic predisposition associated with type 2 diabetes: findings from a national prospective cohort study. Sci Total Environ. (2022) 849:157838. doi: 10.1016/j.scitotenv.2022.157838 [DOI] [PubMed] [Google Scholar]
- 13.Tian F, Cai M, Li H, Qian ZM, Chen L, Zou H, et al. Air pollution associated with incident stroke, Poststroke cardiovascular events, and death: a trajectory analysis of a prospective cohort. Neurology. (2022) 99:e2474–84. doi: 10.1212/wnl.0000000000201316, [DOI] [PubMed] [Google Scholar]
- 14.Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. (2022) 23:40–55. doi: 10.1038/s41580-021-00407-0, [DOI] [PubMed] [Google Scholar]
- 15.Adams R, Henry KE, Sridharan A, Soleimani H, Zhan A, Rawat N, et al. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis. Nat Med. (2022) 28:1455–60. doi: 10.1038/s41591-022-01894-0, [DOI] [PubMed] [Google Scholar]
- 16.Zhang M, Xu Y, Xing Y, Li H. Association between multimorbidity and intrinsic capacity among older Chinese adults: evidence from the CHARLS 2011-2015. Eur Geriatr Med. (2025) 16:1207–16. doi: 10.1007/s41999-025-01232-w, [DOI] [PubMed] [Google Scholar]
- 17.Zhang X, Wang S, Zhou X, Tang Y, Xing L, Ma S, et al. A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial. BMJ. (2025) 389:e082765. doi: 10.1136/bmj-2024-082765, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chen Y, Wang C, Liu X, Duan M, Xiang T, Huang H. Machine learning-based coronary heart disease diagnosis model for type 2 diabetes patients. Front Endocrinol (Lausanne). (2025) 16:1550793. doi: 10.3389/fendo.2025.1550793, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wang Z, Gu Y, Huang L, Liu S, Chen Q, Yang Y, et al. Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data. Cardiovasc Diabetol. (2024) 23:351. doi: 10.1186/s12933-024-02439-0, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Li Z, Wei C, Zhang Z, Han L. ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification. Front Pharmacol. (2024) 15:1375112. doi: 10.3389/fphar.2024.1375112, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sultan SQ, Javaid N, Alrajeh N, Aslam M. Machine learning-based stacking ensemble model for prediction of heart disease with explainable AI and K-fold cross-validation: a symmetric approach. Symmetry (Basel). (2025) 17:185. doi: 10.3390/sym17020185 [DOI] [Google Scholar]
- 22.Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Lopez Ridaura R, et al. Data resource profile: the World Health Organization study on global AGEing and adult health (SAGE). Int J Epidemiol. (2012) 41:1639–49. doi: 10.1093/ije/dys210, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wu F, Guo Y, Kowal P, Jiang Y, Yu M, Li X, et al. Prevalence of major chronic conditions among older Chinese adults: the study on global AGEing and adult health (SAGE) wave 1. PLoS One. (2013) 8:e74176. doi: 10.1371/journal.pone.0074176, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Otieno P, Asiki G, Wilunda C, Wami W, Agyemang C. Cardiometabolic multimorbidity and associated patterns of healthcare utilization and quality of life: results from the study on global AGEing and adult health (SAGE) wave 2 in Ghana. PLOS Glob Public Health. (2023) 3:e0002215. doi: 10.1371/journal.pgph.0002215, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aheto JMK, Udofia EA, Kallson E, Mensah G, Nadia M, Nirmala N, et al. Prevalence, socio-demographic and environmental determinants of asthma in 4621 Ghanaian adults: evidence from wave 2 of the World Health Organization's study on global AGEing and adult health. PLoS One. (2020) 15:e0243642. doi: 10.1371/journal.pone.0243642, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zhang N, Liu X, Wang L, Zhang Y, Xiang Y, Cai J, et al. Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study. Cardiovasc Diabetol. (2024) 23:265. doi: 10.1186/s12933-024-02347-3, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zheng Y, Zhang C, Liu Y. Risk prediction models of depression in older adults with chronic diseases. J Affect Disord. (2024) 359:182–8. doi: 10.1016/j.jad.2024.05.078, [DOI] [PubMed] [Google Scholar]
- 28.Mao L, Lin L, Shi Z, Song H, Zhao H, Xu X. Determinants and prediction of hypertension among Chinese middle-aged and elderly adults with diabetes: a machine learning approach. Heliyon. (2024) 10:e38124. doi: 10.1016/j.heliyon.2024.e38124, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lee H, Hwang SH, Park S, Choi Y, Lee S, Park J, et al. Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study. EClinicalMedicine. (2025) 80:103069. doi: 10.1016/j.eclinm.2025.103069, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. (2012) 380:37–43. doi: 10.1016/S0140-6736(12)60240-2, [DOI] [PubMed] [Google Scholar]
- 31.Benavidez GA, Zahnd WE, Hung P, Eberth JM. Chronic disease prevalence in the US: sociodemographic and geographic variations by zip code tabulation area. Prev Chronic Dis. (2024) 21:E14. doi: 10.5888/pcd21.230267, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kivimaki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. (2017) 2:e277–85. doi: 10.1016/S2468-2667(17)30074-9, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: a cohort study. PLoS Med. (2018) 15:e1002571. doi: 10.1371/journal.pmed.1002571, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Xu X, Mishra GD, Dobson AJ, Jones M. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study. PLoS Med. (2018) 15:e1002516. doi: 10.1371/journal.pmed.1002516, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. (2015) 350:h1551–1. doi: 10.1136/bmj.h1551, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. (2019) 40:537–57. doi: 10.1210/er.2018-00184, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tang GY, Meng X, Li Y, Zhao CN, Liu Q, Li HB. Effects of vegetables on cardiovascular diseases and related mechanisms. Nutrients. (2017) 9:857. doi: 10.3390/nu9080857, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hackett RA, Steptoe A. Type 2 diabetes mellitus and psychological stress - a modifiable risk factor. Nat Rev Endocrinol. (2017) 13:547–60. doi: 10.1038/nrendo.2017.64, [DOI] [PubMed] [Google Scholar]
- 39.Levine GN, Cohen BE, Commodore-Mensah Y, Fleury J, Huffman JC, Khalid U, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association. Circulation. (2021) 143:e763–83. doi: 10.1161/cir.0000000000000947, [DOI] [PubMed] [Google Scholar]
- 40.Chen H, Burnett RT, Kwong JC, Villeneuve PJ, Goldberg MS, Brook RD, et al. Risk of incident diabetes in relation to long-term exposure to fine particulate matter in Ontario, Canada. Environ Health Perspect. (2013) 121:804–10. doi: 10.1289/ehp.1205958, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Marchini T, Zirlik A, Wolf D. Pathogenic role of air pollution particulate matter in Cardiometabolic disease: evidence from Mice and humans. Antioxid Redox Signal. (2020) 33:263–79. doi: 10.1089/ars.2020.8096, [DOI] [PubMed] [Google Scholar]
- 42.Rajagopalan S, Brook RD. Air pollution and type 2 diabetes: mechanistic insights. Diabetes. (2012) 61:3037–45. doi: 10.2337/db12-0190, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Huang C, Chu C, Wang X, Barnett AG. Unusually cold and dry winters increase mortality in Australia. Environ Res. (2015) 136:1–7. doi: 10.1016/j.envres.2014.08.046, [DOI] [PubMed] [Google Scholar]
- 44.Saeki K, Obayashi K, Kurumatani N. Platelet count and indoor cold exposure among elderly people: a cross-sectional analysis of the HEIJO-KYO study. J Epidemiol. (2017) 27:562–7. doi: 10.1016/j.je.2016.12.018, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hu J, Gong W, Yin P, He G, Qin M, Hou Z, et al. Central heating and winter mortality in China: a national study based on 364 Chinese locations. Urban Clim. (2022) 41:101045. doi: 10.1016/j.uclim.2021.101045 [DOI] [Google Scholar]
- 46.Xue X, Fang J, Li Q, Zhu Y, Zhou L, Lei J, et al. Cardiovascular benefits of air purification in children: comprehensive insights from a randomized, double-blind, crossover trial. Environ Sci Technol. (2025) 59:23714–26. doi: 10.1021/acs.est.5c06712, [DOI] [PubMed] [Google Scholar]
- 47.Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. (2016) 594:2061–73. doi: 10.1113/jp270538, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lewis ED, Wu D, Meydani SN. Age-associated alterations in immune function and inflammation. Prog Neuro-Psychopharmacol Biol Psychiatry. (2022) 118:110576. doi: 10.1016/j.pnpbp.2022.110576, [DOI] [PubMed] [Google Scholar]
- 49.Liu J, Liu W, Wang L, Wang N, Wu L, Liu X, et al. Association of Visceral Adiposity Index and Handgrip Strength with Cardiometabolic multimorbidity among middle-aged and older adults: findings from Charls 2011-2020. Nutrients. (2024) 16:2277. doi: 10.3390/nu16142277, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wang B, Zhou Y, Xiao L, Guo Y, Ma J, Zhou M, et al. Association of lung function with cardiovascular risk: a cohort study. Respir Res. (2018) 19:214. doi: 10.1186/s12931-018-0920-y, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zhang J, Wang J, Ma X, Wang Y, Liu K, Li Z, et al. Rapid FEV1 decline and the effects of both FEV1 and FVC on cardiovascular disease: a UK biobank cohort analysis. BMC Public Health. (2024) 24:3214. doi: 10.1186/s12889-024-20716-1, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. (2014) 2:819–29. doi: 10.1016/s2213-8587(14)70034-8, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wilkins MR, Ghofrani HA, Weissmann N, Aldashev A, Zhao L. Pathophysiology and treatment of high-altitude pulmonary vascular disease. Circulation. (2015) 131:582–90. doi: 10.1161/circulationaha.114.006977, [DOI] [PubMed] [Google Scholar]
- 54.Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. Hypertension. (2010) 56:563–70. doi: 10.1161/hypertensionaha.110.157339, [DOI] [PubMed] [Google Scholar]
- 55.McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. (2006) 48:602–8. doi: 10.1161/01.HYP.0000239206.64270.5f [DOI] [PubMed] [Google Scholar]
- 56.Guo Z, Chen Y, Koirala B, Li J, Jia Y, Dennison Himmelfarb CR, et al. Intrinsic capacity trajectories and cardiovascular disease incidence among Chinese older adults: a population-based prospective cohort study. BMC Geriatr. (2025) 25:269. doi: 10.1186/s12877-025-05910-z, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Ramírez-Vélez R, Iriarte-Fernández M, Santafé G, Malanda A, Beard JR, Garcia-Hermoso A, et al. Association of intrinsic capacity with incidence and mortality of cardiovascular disease: prospective study in UK biobank. J Cachexia Sarcopenia Muscle. (2023) 14:2054–63. doi: 10.1002/jcsm.13283, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sánchez-Sánchez JL, Lu WH, Gallardo-Gómez D, Del Pozo Cruz B, de Souto Barreto P, Lucia A, et al. Association of intrinsic capacity with functional decline and mortality in older adults: a systematic review and meta-analysis of longitudinal studies. Lancet Healthy Longev. (2024) 5:e480–92. doi: 10.1016/s2666-7568(24)00092-8, [DOI] [PubMed] [Google Scholar]
- 59.Zeng X, Shen S, Xu L, Wang Y, Yang Y, Chen L, et al. The impact of intrinsic capacity on adverse outcomes in older hospitalized patients: a one-year follow-up study. Gerontology. (2021) 67:267–75. doi: 10.1159/000512794, [DOI] [PubMed] [Google Scholar]
- 60.Boutari C, Hill MA, Procaccini C, Matarese G, Mantzoros CS. The key role of inflammation in the pathogenesis and management of obesity and CVD. Metabolism. (2023) 145:155627. doi: 10.1016/j.metabol.2023.155627, [DOI] [PubMed] [Google Scholar]
- 61.Vaccarino V, Bremner JD. Stress and cardiovascular disease: an update. Nat Rev Cardiol. (2024) 21:603–16. doi: 10.1038/s41569-024-01024-y, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kirkwood TB. Understanding the odd science of aging. Cell. (2005) 120:437–47. doi: 10.1016/j.cell.2005.01.027, [DOI] [PubMed] [Google Scholar]
- 63.Marmot M, Friel S, Bell R, Houweling TA, Taylor S. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. (2008) 372:1661–9. doi: 10.1016/s0140-6736(08)61690-6, [DOI] [PubMed] [Google Scholar]
- 64.Vasan RS, Zachariah JP, Xanthakis V. Life course developmental approach to cardiovascular health and cardiovascular disease prevention: opportunities and unanswered questions. J Am Coll Cardiol. (2020) 76:2708–11. doi: 10.1016/j.jacc.2020.10.011, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European renal association (ERA). J Hypertens. (2023) 41:1874–2071. doi: 10.1097/hjh.0000000000003480, [DOI] [PubMed] [Google Scholar]
- 66.Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Cooper C, Martin FC, Reginster JY, et al. Evidence for the domains supporting the construct of intrinsic capacity. J Gerontol A Biol Sci Med Sci. (2018) 73:1653–60. doi: 10.1093/gerona/gly011, [DOI] [PubMed] [Google Scholar]
- 67.Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. (2013) 381:752–62. doi: 10.1016/s0140-6736(12)62167-9, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Su X, Cheung CYY, Zhong J, Ru Y, Fong CHY, Lee CH, et al. Ten metabolites-based algorithm predicts the future development of type 2 diabetes in Chinese. J Adv Res. (2024) 64:131–42. doi: 10.1016/j.jare.2023.11.026, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. (2025) 24:257. doi: 10.1186/s12933-025-02819-0, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Mahajan P, Uddin S, Hajati F, Moni MA, Gide E. A comparative evaluation of machine learning ensemble approaches for disease prediction using multiple datasets. Health Technol (Heidelb). (2024) 14:597–613. doi: 10.1007/s12553-024-00835-w [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data analyzed in this study is subject to the following licenses/restrictions: the datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Requests to access these datasets should be directed to heguanh1991@163.com (GH).




